EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 27 / Numéro 4 (Avril 2011) Med Sci (Paris), 27 4 (2011) 443-446 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 4, Avril 2011
Page(s) 443 - 446
Section Dernière heure
DOI https://doi.org/10.1051/medsci/2011274023
Publié en ligne 28 avril 2011
  1. MarteynA, MauryY, GauthierMM, et al. Mutant human embryonic stem cells reveal neurite and synapse formation defects in Type 1 myotonic dystrophy. Cell Stem Cell 2011 ; online. [Google Scholar]
  2. EigesR, UrbachA, MalcovM, et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007 ; 5 : 568-577. [CrossRef] [Google Scholar]
  3. TakahashiK, TanabeK, OhnukiM, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. cell 2007 ; 5 : 861-872. [Google Scholar]
  4. GoreA, LiZ, FungHL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011 ; 471 : 63-67. [CrossRef] [PubMed] [Google Scholar]
  5. HusseinSM, BatadaNN, VuoristoS, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011 ; 471 : 58-62. [CrossRef] [PubMed] [Google Scholar]
  6. ListerR, PelizzolaM, KidaYS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011 ; 471 : 68-73. [CrossRef] [PubMed] [Google Scholar]
  7. UrbachA, Bar-NurO, DaleyGQ, BenvenistyN.. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2007 ; 5 : 407-411. [Google Scholar]
  8. RanumLP, CooperTA.. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006 ; 29 : 259-277. [CrossRef] [PubMed] [Google Scholar]
  9. JiangH, MankodiA, SwansonMS, et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004 ; 24 : 3079-3088. [CrossRef] [Google Scholar]
  10. StranockSD, DavisJN.. Ultrastructure of the muscle spindle in dystrophia myotonica. II. The sensory and motor nerve terminals. Neuropathol Appl Neurobiol 1978 ; 5 : 407-418. [CrossRef] [Google Scholar]
  11. PanaitePA, GanteletE, KraftsikR, et al. Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves. J Neuropathol Exp Neurol 2008 ; 8 : 763-772. [CrossRef] [Google Scholar]
  12. NagaoM, KatoS, HayashiH, MisawaH.. Hyperproliferation of synapses on spinal motor neurons of Duchenne muscular dystrophy and myotonic dystrophy patients. Acta Neuropathol 2003 ; 6 : 557-560. [CrossRef] [Google Scholar]
  13. ParkIH, AroraN, HuoH, et al. Disease-specific induced pluripotent stem cells. Cell 2008 ; 134 : 877-886. [CrossRef] [PubMed] [Google Scholar]
  14. KazukiY, HiratsukaM, TakiguchiM, et al. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther 2009 ; 2 : 386-393. [Google Scholar]
  15. SoldnerF, HockemeyerD, BeardC, et al. disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009 ; 5 : 964-977. [CrossRef] [Google Scholar]
  16. HargusG, CooperO, DeleidiM, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010 ; 107 : 15921-15926. [CrossRef] [Google Scholar]
  17. MaehrR, ChenS, SnitowM, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009 ; 37 : 15768-15773. [CrossRef] [Google Scholar]
  18. BaekKH, ZaslavskyA, LynchRC, et al. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009 ; 7250 : 1126-1130. [CrossRef] [Google Scholar]
  19. EbertAD, YuJ, RoseFFJr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009 ; 7227 : 277-280. [CrossRef] [PubMed] [Google Scholar]
  20. LeeG, PapapetrouEP, KimH, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009 ; 7262 : 402-406. [CrossRef] [Google Scholar]
  21. DimosJT, RodolfaKT, NiakanKK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008 ; 5893 : 1218-1221. [CrossRef] [PubMed] [Google Scholar]
  22. HottaA, CheungAY, FarraN, et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009 ; 5 : 370-376. [CrossRef] [Google Scholar]
  23. MarchettoMC, CarromeuC, AcabA, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010 ; 4 : 527-539. [CrossRef] [PubMed] [Google Scholar]
  24. CheungAY, HorvathLM, GrafodatskayaD, Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 2011, 17 mars (online). [Google Scholar]
  25. YeL, ChangJC, LinC, et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009 ; 24 : 9826-9830. [CrossRef] [Google Scholar]
  26. WangY, JiangY, LiuS, et al. Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells. Cell Res 2009 ; 9 : 1120-1123. [CrossRef] [Google Scholar]
  27. ZhangJ, LianQ, ZhuG, et al. A human iPSC model of Hutchinson-Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2010 ; 1 : 31-45. [Google Scholar]
  28. LiuGH, BarkhoBZ, RuizS, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011, 23 février(online). [Google Scholar]
  29. MorettiA, BellinM, WellingA, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010 ; 15 : 1397-1409. [CrossRef] [Google Scholar]
  30. ItzhakiI, MaizelsL, HuberI, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011 ; 7337 : 225-229. [CrossRef] [Google Scholar]
  31. MatsaE, RajamohanD, DickE, et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 2011 ; 2 mars (online). [Google Scholar]
  32. YazawaM, HsuehB, JiaX, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011 ; 7337 : 230-234. [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.